TB-500 for Inflammation: What the Evidence Shows
What human and animal studies show about TB-500 for inflammation, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 78
- PubMed records, our ledger
- Animal studies
- 80
- PubMed records, our ledger
- Studies we summarised
- 2
- with an outcome for inflammation
Evidence for inflammation
Each row is an outcome related to inflammation from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Scalp seborrheic dermatitis | The thymosin beta-4 gel was reported more effective than ketoconazole lotion for scalp seborrheic dermatitis (randomization not stated in abstract). | Human controlled trialn = 71 | Microbial biotechnology 2021, PMID 34318587 |
| Corneal alkali burn | The peptide-containing hydrogel accelerated corneal epithelial regeneration and reduced inflammation in an alkali burn model; this is a formulation study. | Animal · human corneal cells in vitro plus an animal alkali burn model (species not stated in abstract) (not a human result) | ACS applied materials & interfaces 2025, PMID 41359360 |
PubMed records for TB-500 and inflammation: 78 human, 80 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What inflammation means here
MedlinePlus defines inflammation as the body's way of protecting tissues and helping them heal from injury, infection or other disease.[3]
Studies closest to inflammation
In an alkali-burn animal model, a hydrogel carrying the TB500 sequence reduced inflammation and sped epithelial regeneration. No person was treated.[2]
In the one human study tied to an inflammatory skin disease, a recombinant full-length thymosin beta-4 gel (not TB-500) did better than ketoconazole lotion in seborrheic dermatitis.[1]
How much literature sits behind the goal
A dated PubMed count (query stored with the goal data, run 2026-10-02) found 78 human-only and 80 animal-only records for thymosin beta-4 or TB-500 terms combined with inflammation terms. Counts are of papers mentioning both, not of trials showing an effect.
Calculated from goal inflammation; peptide tb-500; method pubmed-tiab-v1; date 2026-10-02; query ("TB-500"[tiab] OR TB500[tiab] OR "thymosin beta-4"[tiab] OR "thymosin beta4"[tiab] OR Tbeta4[tiab]) AND (inflammat*[tiab] OR colitis[tiab] OR "C-reactive protein"[tiab] OR "tumor necrosis factor"[tiab] OR "tumour necrosis factor"[tiab]); human records 78; animal records 80. Formula: records returned by the stored query: humans NOT animals filter = humanRecords; animals NOT humans filter = animalRecords
Other peptides people research for inflammation
All peptides for inflammation, comparedCommon questions
Does TB-500 help with inflammation?
The strongest study we summarise for inflammation is human rct evidence, across 2 studies with an outcome for inflammation. A trial result is not an approval; see the legal status.
Is TB-500 approved for inflammation?
No. TB-500 is not FDA approved for any use, including inflammation.
What is the best peptide for inflammation?
There is no single answer. Our inflammation overview compares each candidate by evidence grade and legal status rather than by popularity.
Is TB-500 anti-inflammatory?
A horse doping paper repeats the claim that TB-500 decreases inflammation but tested detection, not inflammation.[4]
More on TB-500
Sources
- 1Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
- 2Alkaline Phosphatase-Triggered Spatiotemporal Repair of Corneal Injury with TB500 Peptide Hydrogel.ACS applied materials & interfaces · 2025PMID 41359360Accessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.Journal of chromatography. A · 2012PMID 23084823Accessed 2 Oct 2026
Found an error? Report a correction.